Evaluating visual field changes in glaucoma patients
Official title: An Observational Prospective Longitudinal Study for the Clinical Evaluation of Visual Field Change in Glaucoma. An Assessment of Different Models of Progression
Run by Centervue SpA · NCT05801471 · Data updated 2026-11-12
This study is trying to see how different ways of measuring vision changes can help track the progression of glaucoma in patients over three years.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 40 Years to 90 Years |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | Centervue SpA Industry-sponsored |
| Locations | 2 sites (Milan, Milano and 1 other locations) |
| Status | Recruiting |
| Started | May 6, 2022 |
| Main results expected | November 6, 2028 |
| Study ends | November 6, 2028 |
| Registry record updated | January 2, 2026 |
| Trial ID | NCT05801471 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals aged 40 to 90 with glaucomatous optic nerve head in both eyes and specific visual acuity and refraction criteria.
✕Probably not a fit
Patients with advanced glaucoma or other ocular conditions that could affect visual field assessments may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to collect data over a 36-month period from patients with glaucoma to assess various methods for defining the progression of the disease. Participants will undergo repeated visits where their retinal functionality will be evaluated using the COMPASS fundus perimeter and the Humphrey Field Analyzer (HFA). Additionally, Optical Coherence Tomography (OCT) will be performed to gather clinical information about the retinal structure. The study focuses on understanding how different models can effectively track changes in visual fields associated with glaucoma.
Why it matters
Potential benefit: If successful, this study could lead to improved methods for monitoring glaucoma progression, enhancing patient management and treatment outcomes.
How similar studies have gone: While similar observational studies have been conducted, this specific approach to evaluating visual field progression in glaucoma is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Glaucomatous optic nerve head in both eyes; * Age between 40 and 90 years; * Best Corrected Visual Acuity ≤ 0.3 \[logMar\]; * Spherical refraction between -6D and +6D; * Astigmatism between -2D and +2D. Exclusion Criteria: * Any ocular surgery, except for: uncomplicated cataract surgery and/or glaucoma surgery in both eyes performed within 6 months before enrollment; * Any ocular pathology that can affect visual field other than glaucoma; * Use of any drug that can interfere with the correct execution of perimetry or that would produce visual field loss; * Inability to obtain reliable perimetric examinations; * Patients with advanced glaucoma for whom, according to the clinician, a 24-2 grid is not advisable to correctly monitor the patient.
Where it's running
-
Clinica oculistica Ospedale San Paolo
Milan, Milano, Italy Recruiting -
Glaucoma Research Center, IRCCS Fondazione "G.B. Bietti"
Roma, Roma, Italy Recruiting
Study contacts
- Principal investigator: Luca M. Rossetti, Prof. — Clinica oculistica Ospedale San Paolo
- Study coordinator: Chiara Rui
- Email: chiara.rui@icare-world.com
- Phone: +39 049 501 8399
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Balance training for people with glaucoma
A randomized study tests whether a structured eight-week balance program helps adults with glaucoma improve balance, reduce fall risk, and lessen fear of falling.
-
Eye drops Rhopressa vs Timolol to protect nerve cells in glaucoma
In adults with open-angle glaucoma, this study tests whether Rhopressa helps preserve retinal nerve cells better than Timolol while both lower eye pressure.
-
Comparison of FT-1000 non-contact tonometry with Goldmann applanation tonometry in glaucoma patients
This study tests whether the FT-1000 non-contact tonometer gives measurements that agree with the Goldmann applanation tonometer in adults with glaucoma.
-
Removing the ripcord from a glaucoma drainage device after 3 months
This study tests whether removing the ripcord from an implanted glaucoma drainage device changes eye pressure for adults with open-angle glaucoma.
-
Glaucoma and Brain Changes: How Brain Structure and Size See What Glaucoma Is Doing
This study tests whether glaucoma is linked to broader brain changes by comparing brain MRI and eye health over time in people with glaucoma and matched controls.
-
Long-Term Results After Ab-interno Trabeculotomy for Glaucoma
This study tests whether ab-interno trabeculotomy with the Trabectome can provide sustained intraocular pressure reduction in glaucoma patients who had the procedure between 2019 and 2021.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.